ZYXIQ
ZYNEX INCPrice & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ZYXIQ
this stock
ZYNEX INC
|
$1.69M | -56.3% | +16.5% | — | 3.9% |
|
MCK
Mckesson Corp
|
$94.52B | -4.1% | +3.1% | 20.5 | 3.7% |
|
COR
Cencora, Inc.
|
$57.69B | -12.1% | +9.3% | — | 3.2% |
|
CAH
Cardinal Health Inc
|
$56.23B | +16.8% | -1.9% | — | 3.8% |
|
HSIC
Henry Schein Inc
|
$9.85B | +14.4% | +5.9% | 26.1 | 6.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- % held
- 0.0%
- Net QoQ
- -206.3K sh
- Top holder
- HUNTINGTON NATIONAL BANK
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ZYXIQ | -23.1% | -38.9% | — | -31.3% | -56.4% |
| SPY | -2.2% | -6.4% | -3.6% | -6.0% | -5.4% |
| vs SPY | -20.9% | -32.5% | — | -25.3% | -51.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.